6 completed. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Hydralazine on Alzheimer's Disease Hydralazine hydrochloride 25mg tablets, Placebo - Alzheimer Disease | Phase 3 | Completed | Shahid Sadoughi University of Medical Sciences and Health Services | 228 | 2021-08-02 | 2026-09-09 |
| Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19 Platelet rich plasma (PRP), olfactory training - Anosmia, COVID-19 | Phase 2 / Phase 3 | Completed | Centre Hospitalier Universitaire Saint Pierre | 56 | 2021-02-01 | 2022-02-25 |
| Intranasal Insulin for COVID-19-related Smell Loss Insulin - Anosmia, Smell Loss | Phase 3 | Completed | Universidad Panamericana | 27 | 2021-01-04 | 2022-07-18 |
| Corticosteroid Nasal Spray in COVID-19 Anosmia mometasone furoate nasal spray - Covid19, Anosmia | Phase 3 | Completed | Benha University | 100 | 2020-08-08 | 2020-11-13 |
| Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia Cerebrolysin - Covid19 Related Anosmia and Aguesia | Phase 3 | Completed | Assiut University | 250 | 2020-08-01 | 2023-01-03 |
| Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity Budesonide Nasal, Physiological serum - Budesonide, Olfaction Disorders | Phase 3 | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 120 | 2020-05-18 | 2026-01-06 |
Anosmia (6) · COVID-19 (4) · Ageusia (1) · Alzheimer Disease (1)
Nervous System Diseases (6) · Neurologic Manifestations (6) · Pathological Conditions, Signs and Symptoms (6) · Sensation Disorders (6) · Signs and Symptoms (6) · Coronaviridae Infections (4) · Coronavirus Infections (4) · Infections (4) · Lung Diseases (4) · Nidovirales Infections (4) · Pneumonia (4) · Pneumonia, Viral (4) · RNA Virus Infections (4) · Respiratory Tract Diseases (4)
Control Groups (1) · Hydralazine (1) · Insulin (1) · Olfactory Training (1) · cerebrolysin (1)
Assiut University (1) · Benha University (1) · Centre Hospitalier Universitaire Saint Pierre (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Shahid Sadoughi University of Medical Sciences and Health Services (1) · Universidad Panamericana (1)
Egypt (2) · Belgium (1) · France (1) · Iran (1) · Mexico (1)
Abdelhakim F Ghallab, MD (1) · Abdelrahman A Abdelalim, MD (1) · Ayman A Mohamady, MD (1) · Mihaela Horoi, PhD (1) · Mona A Elawady, MD (1) · Rasha A Elsayed, MD (1) · Sherifa A Hamed, M.D. (1)
PMID 29557250, PMID 32253535, PMID 32690074, PMID 33429174, PMID 33862126, PMID 35904632, PMID 36063364, PMID 37652094, PMID 37950370